French pharmaceutical company Sanofi-Aventis SA may initiate a hostile takeover of US biotech company Genzyme Corp. if the management of the latter refuses the acquisition offer, Citgroup Inc. analysts believe. Mark Dainty and Yaron Werber.
French pharmaceutical company Sanofi-Aventis SA may initiate a hostile takeover of US biotech company Genzyme Corp. if the management of the latter refuses the acquisition offer, Citgroup Inc. analysts believe. Mark Dainty and Yaron Werber.